iSTAR Medical Overview
Pro stress-test →iSTAR Medical is a medtech company delivering breakthrough eye care solutions through minimally-invasive implants with bio-integration. Its flagship product MINIject is a microinvasive glaucoma surgery (MIGS) device designed to effectively reduce intraocular pressure (IOP) in patients with primary open-angle glaucoma. MINIject has been approved in Europe for treatment of glaucoma – the leading cause of irreversible blindness.
Strategic Profile
Pro stress-test →The device is made from a proprietary material known as STAR, which is notable for its anti-fibrotic and anti-inflammatory properties. In July 2022, AbbVie and iSTAR Medical announced a strategic transaction to further develop and commercialize MINIject, providing support for iSTAR Medical's development and commercial efforts while expanding AbbVie's eye care business. The company is aiming to seek market approval in the US.
Competitive Landscape
Pro stress-test →Top competitors include Nova Eye Medical, LIQID Medical and Ciliatech. Ocular Therapeutix is also a competitor in the MIGS device space. iSTAR Medical differentiates through its proprietary STAR material technology and demonstrated long-term clinical efficacy, with strategic backing from AbbVie providing scale and commercial reach advantages.
Industry Context
iSTAR Medical operates in Minimally invasive glaucoma surgery (MIGS) devices.
Key facts
Founded: 2010 · Headquarters: Wavre, Belgium · Employees: 51-200 · Revenue: $18.5M